Clinical Trials Directory

Trials / Conditions / Poor Graft Function

Poor Graft Function

12 registered clinical trials studyying Poor Graft Function — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingThe Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Functi
NCT06792682
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1
RecruitingCD34+ Selected Stem Cell for Poor Graft Function or Graft Failure
NCT06569082
NYU Langone HealthN/A
Not Yet RecruitingREscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transp
NCT06607367
Melbourne HealthPhase 1 / Phase 2
Not Yet RecruitingDecitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
NCT05669079
The First Affiliated Hospital of Soochow UniversityPhase 3
Not Yet RecruitingDecitabine for Poor Graft Function Post Allo-HSCT
NCT05907499
The First Affiliated Hospital of Soochow UniversityPhase 3
TerminatedStudy of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function
NCT03718533
Novartis PharmaceuticalsPhase 2
UnknownEltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation
NCT03437603
The First Affiliated Hospital of Soochow UniversityPhase 2
UnknownMSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engr
NCT02240992
Nanfang Hospital, Southern Medical UniversityPhase 2 / Phase 3
UnknownPeripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function
NCT02083718
Nanfang Hospital, Southern Medical UniversityPhase 2
CompletedG-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation
NCT01857336
Peking University People's HospitalN/A
UnknownMesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplan
NCT01763086
Nanfang Hospital, Southern Medical UniversityPhase 2
RecruitingMesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Po
NCT00603330
University of LiegePhase 2